Headway's zero-fee provider push
Rula
Headway is using therapist economics as its main wedge, which turns provider acquisition into the core battle in managed mental health marketplaces. When a solo therapist compares platforms, the decision is simple and concrete, who brings insured patients, who handles credentialing and claims, who pays fast, and how much of each $100 to $150 reimbursement the therapist keeps. Headway removes upfront fees entirely, while Rula keeps a share of reimbursement, so payout differences can directly pressure Rula's take rate and margins.
-
Headway pairs free access with a full back office. It handles credentialing, billing, collections, and pays clinicians twice monthly before insurers reimburse, which makes the pitch more than lower fees. It is effectively cash flow plus admin relief plus patient demand in one offer.
-
The competitive set monetizes providers in visibly different ways. Rula appears to keep roughly 25% of reimbursement. Alma charges about $125 per month plus a claims percentage. Headway charges no membership fee and in some internal comparisons is described as taking 25% to 30% from reimbursements, showing how pricing can flex by product mix and market.
-
This matters because scale compounds. Headway has been described with 48,000 to 70,000 plus providers across sources, and reported 6,000,000 plus hours of care in 2024. A larger therapist base improves patient match rates and payer relevance, which then helps attract even more therapists.
The next phase is likely a shift from simple fee competition to deeper lock in. As platforms add EHR, referrals from primary care, psychiatry, and public insurance contracts, the winner will be the one that makes an insurance based private practice easiest to run every day, while still leaving therapists with the strongest earnings per session.